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Clinical Manifestations of Acute Pulmonary Embolism: Henry Ford
Hospital Experience, A Five-Year Review
Kenneth V. Leeper, Jr, MD,* John Popovich, Jr, MD,* Deborah Adams, BSN,* and
Paul D. Stein, MD^
Clinical findings of 112 patients with angiographically proven pulmonary embolism over a five-year
period were analyzed. Recent immobilization, chronic heart disease, deep venous thrombosis,
malignancy, and recent surgery were the most frequent predisposing faclors. Only 5% had no
identifiable risk factors. Presenting syndromes were circulatory collapse (25%), pulmonary infarction
(59%), and uncomplicated pulmonary embolism (18%). Dyspnea and pleuritic chest pain were the
predominant symptoms. The combination of dyspnea, pleuritic chest pain, and hemoptysis occurred
in 23% ofthe patients. The most frequent signs were tachypnea, tachycardia, and rales. Most ofthe
patients demonstrated arterial oxygen tension (PaO^) between 50 and 70 mm Hg, and 9% had a PaO,
greater than 80 mm Hg. The mosl common chest x-ray findings were infiltration and consolidalion,
pleural effusion, and atelectasis. The most common electrocardiographic abnormalities were
nonspecific ST and T-wave changes in 42% of patients. Lung scans were most frequently interpreted
as indeterminate probability. A continuing reassessment of the features of pulmonary embolism
may assist in selecting patients for confirmatory diagnostic studies. (Henry Ford Hosp Med J 1988;
36:29-34)

ulmonary embolism is common yet frequently remains
unrecognized. Consequently, this condition is underdiagnosed, especially in patients with a history of cardiac or pulmonary disease. The mortality rate from untreated pulmonary
embolism is approximately 30% . while correctly diagnosed and
treated patients have a mortality rate of approximately 8% (1).
The clinical features and laboratory findings have been characteristically described as nonspecific in numerous studies (2-4),
which is similarly true for the noninvasive diagnostic studies,
including ventilation perfusion scans (5,6). Because of the nonspecificity of the noninvasive studies, pulmonary angiography
has been used as the "gold standard" in establishing the diagnosis of pulmonary embolism (7,8). Some centers, however,
have reported that only 30% of patients with suspected pulmonary embolism have had pulmonary embolism proven by
angiography (9). Despite the rather grim impression of the
nonspecificity of the clinical diagnosis, some investigators have
shown that the clinical features of pulmonary embolism may be
extremely useful in establishing a preliminary diagnosis (10,11),
thereby eliminating the necessity of performing angiography on
patients in whom the diagnosis is unlikely. In this investigation,
we assess our own experience in an effort to strengthen our diagnostic capabilities.

P

lism identified by this procedure (Table 1). Charts of these 112
patients were reviewed for demographic data, symptoms, and
signs. Reports ofthe chest radiographs, ventilation perfusion
lung scans, and pulmonary angiograms were also reviewed.

Results
Patient population and predisposing factors
The patients with angiographically proven pulmonary embolism included 59 men and 53 women. Their ages ranged from 20
to 89 years.

Table 1
Acute Pulmonary Embolism

Year

Number of Patients
with Suspected Pulmonary
Embolism Undergoing
Angiography

Number of Positive
Angiograms

1980
1981
1982
1983
1984
Total

24
7S
60
65
75
302

12
18
25
27
30
112

Methods
A computer search of the hospital medical records and a
review of the records in Interventional Radiology were undertaken to identify patients who underwent pulmonary angiography for suspected pulmonary embolism from 1980 through
1984. During this five-year period, 302 pulmonary angiograms
were performed and 112 (37%) patients had pulmonary embo-
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Table 2
Incidence of Predisposing Factors in Patients with
Angiographically Proven Pulmonary Embolism

Table 4
Symptoms of 112 Patients with Pulmonary Embolism
Symptom

Condition
Recent immobilization
Chronic heart disease
Neoplasms
Deep venous thrombosis
Recent surgery
Previous pulmonary embolism
Previous thrombophlebitis
Obesity
Trauma
Estrogen-containing drugs
No risk factor

Number

Percent

33
31
27
26
23
13
10
8
6
3
7

29
28
24
23
21
12
9
7
4
3
5

The most frequent predisposing factors included recent immobilization and chronic heart disease which occurred in 29%
and 28% of the patients with proven acute pulmonary embolism,
respectively. Deep venous thrombosis, documented by invasive
or noninvasive methods, was observed in 23% of patients with
acute pulmonary embolism. Eight patients had positive venograms, all demonstrating clots above the knee. Thirteen ofthe
18 patients who had noninvasive studies had clots in the femoral
vein, and five had equivocal studies suggesting femoral vein involvement. Malignancy and recent surgery were predisposing
factors in 24% and 21% of patients, respectively. Less frequent
predisposing factors included a history of pulmonary embolism,
trauma (usually from long bone fractures), or the use of
estrogen-containing dmgs. Obesity as the only identifiable risk
factor was present in 7% of the patients (Table 2). Many of the
patients had multipleriskfactors. However, 5% of the patients
had no recognized risk factor.
Presenting syndromes of acute pulmonary embolism
The syndrome of circulatory collapse (shock or syncope) occurred in 25% of the patients. The pulmonary infarction syndrome (hemoptysis with or without pleuritic pain or pleuritic
pain without hemoptysis) occurred in 59% of patients. Uncomplicated pulmonary embolism (dyspnea alone or nonpleuritic
pain alone) occurred in 18% of patients (Table 3).

Table 3
Presenting Syndromes of Acute Pulmonary
Embolism in 112 Patients with Angiographically Proven
Pulmonary Embolism
Syndrome
Circulatory collapse syndrome
Syncope
Shock
Pulmonary infarction syndrome
Hemoptysis ± pleuritic pain
Pleuritic pain without hemoptysis
Uncomplicated embolism syndrome
Dyspnea
Nonpleuritic pain

30
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Number

Percent

15
14

13
12

25
4(.)

22
.r/

i:
6

II
5

Number

Dyspnea
Pleuritic chest pain
Sudden onset of dyspnea or pleuritic chest pain
Cough
Hemoptysis
Calf pain
Syncope
Chest pain, nonpleuritic
Palpitations

97
66
S2
30
25
16
14
12
9

Percenl
87
5<i
73
27
22
14
13
1 1
8

Symptoms and physical signs
The symptoms and physical signs of the 112 patients with pulmonary emboli are listed in Tables 4 and 5. Dyspnea, the most
frequent symptom, occurred in 87% of the patients. Pleuritic
chest pain occurred in 59%. An acute onset of either dyspnea or
pleuritic chest pain occurred in 73% ofthe patients with pulmonary embolism. Cough, hemoptysis, syncope, nonpleuritic
chest pain, calf pain, and palpitations each occurred in less than
30% ofthe patients (Table 3).
Tachypnea, the most frequent physical sign, occurred in 81%
ofthe patients. Tachycardia and rales were the next most
frequent physicalfindingsat 67%i and 46%, respectively (Table
5). An accentuated pulmonic closure sound, shock, fever (temperature > 37.8°C), pleural rub, and cyanosis were less common, with each noted in less than 20% of the patients (Table 5).
Either dyspnea or tachypnea (5= 20 breaths/min) occurred in
96% of patients. The combination of dyspnea and pleuritic chest
pain occurred in 47% of patients. However, dyspnea, pleuritic
chest pain, and hemoptysis occurred in 23% (Table 6).
Arterial blood oxygen
Eighty-nine (79%) of the 112 patients with proven pulmonary
embolism had arterial blood gases drawn while breathing room
air. The distribution of levels of the arterial PO, is shown in the
Figure. The most frequent range of arterial PO^ was between 50

Table 5
Physical Signs in 112 Patients with Pulmonary Embolism
Physical Signs
Tachypnea (3= 20/min)
Tachycardia (s: lOO/min)
Rales
Accentuated P,
Fever> 37.8°C
Shock (systolic blood pressure < 100 mm Hg)
Jugular venous distension
Fourth heart sound
Third heart sound
Pleural rub
Cyanosis

Number

Percent

91
75
52
18
16
15
14
12
9
5
5

81
67
46
16
14
13
12
11
8
4
4
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Table 6
Combinations of Dyspnea, Pleuritic Pain, and
Hemoptysis in 112 Patients with Angiographically Proven
Pulmonary Embolism
Symptoms
Dyspnea only
Dyspnea + pleuritic pain
Dyspnea + pleuritic pain + hemoptysis
Pleuritic pain
Pleuritic pain -1- hemoptysis
Dyspnea or hemoptysis -1- pleuritic pain

Number

Percent

25
53
26
9
3
97

22
47
23
8
3
87

30.
28
26.
24.
22.
20.
18.
16.
14.
12.
10.
8.
6
4.
2.
0.

20%

30-39

and 59 mm Hg, which occurred in 33% of the patients. An arterial PO, greater than 80 mm Hg was present in 9%, and a PO,
less than 40 mm Hg occurred in 6% of the patients.
Electrocardiographic features
Ofthe 112 patients studied, 83 had identifiable electrocardiograms at the time of the embolic event. The most common
abnormality was nonspecific ST segment or T-wave changes,
which occurred in 57% of patients. A normal electrocardiogram
was seen in 10% of patients. An S1Q3T3 pattem occurred in 7%
of patients. A new right bundle branch block was noted in 14
(17%) of 83 patients, and six of these patients presented with
either shock or syncope. Left axis deviation ( ^ — 30) and right
axis deviation (> 90°) occurred in 7% and 10% of the patients.
New arrhythmias that seemed to accompany the onset of symptoms occurred in 12%, with atrial flutter or fibrillation being
most common in 10% of the patients.
Chest roentgenographic and lung scan findings
The most commonly reported chest x-ray finding was infiltration (43%), followed by pleural effusion (37%). Atelectasis was
noted in 19%. A normal chest x-ray was present in 18%. Ventilation and perfusion scans were obtained prior to pulmonary angiography in 46 (41%) of 112 patients. Of these scans, 22 (48%)
were interpreted as indeterminate probability, 19 (41%) as high
probability, and five (11%) as low probability.
Pulmonary angiography
Only 112 (37%) of the 302 patients who underwent pulmonary
angiography had demonstrable pulmonary emboli. No angiographically related deaths occurred among these 112 patients.
Ofthe 112 patients with pulmonary embolism, 108 had bilateral
angiograms in which the most frequent lobar locations for emboli were the right lower lobe (36%) and the left lower lobe
(33%). Right atrial, right ventricular, and pulmonary artery
pressures were not consistently recorded. Ofthe 108 bilateral
angiograms, 62% had bilateral involvement. One patient had a
pulmonary digital subtraction angiogram which demonstrated a
right lower lobe embolus.

Discussion
Pulmonary embolism is not a disease but a complication of
deep venous thrombosis. The factors responsible for the development of deep venous thrombosis are obviously the major
determinants for subsequent pulmonary embolization. As indi-
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Figure—Ranges of partial pressure of oxygen in arterial blood
(PaO,). The numbers in the bars indicate the percentage of
patients with the indicated PaO,.
cated in Table 2, recent immobilization, chronic heart disease,
documented deep venous thrombosis, recent surgery, and malignancy were the most frequent predisposing factors. All of the
patients in our study who had documented deep venous thrombosis by phleborheography or venography had findings suggestive of proximal deep venous thrombosis (involvement of the
veins of the thigh). Moser and LeMoine (12) demonstrated that
proximal deep venous thrombosis carries a greaterriskof embolization than distal (calf) venous thrombosis.
Chronic heart disease is a major risk factor for the development of thromboembolic disease, especially in patients observed with both atrial fibrillation and congestive heart failure
(13). Chronic heart disease occurred in 28% of our patients, with
most patients suffering from recurrent congestive heart failure.
Individuals who weigh 20% more than the standard weight
for their age, sex, and frame have an increased incidence of
thromboembolic disease (14). Adiposity in women was noted to
be a factor for significant pulmonary embolism at autopsy (15).
Obesity was the only identifiableriskfactor in 7% of the patients
in our study.
The association between malignancy and recurrent thromboembolic disease was first described by Trousseau (16). It has
been suggested that recurrent pulmonary embolic events may
presage the diagnosis of an occult neoplasm (17). In a review by
Gore et al (17), an increased incidence of cancer of the
breast, gastrointestinal tract, lung, and uterus was observed for
two years following the diagnosis of deep venous thrombosis
and pulmonary embolism. A shift in patients undergoing pulmonary angiography for suspected pulmonary embolism, from
patients with primary cardiovascular disease to patients with
neoplastic disease, has been reported (18). Malignancy was
noted to be a majorriskfactor (24% of patients) in the development of pulmonary embolism in our review, which was comparable to the incidence in patients with chronic heart disease
(28%). Lung, pancreas, gastric, and colonic neoplasms were
the usual tumors associated with pulmonary embolic events in
our patients.
The determination of an identifiable predisposing risk factor
is important in formulating a clinical diagnosis of pulmonary
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embolism. Of 215 patients with angiographically proven embolism and no preexisting cardiac or pulmonary disease, Stein et al
(11) found that predisposing risk factors occurred in 76% of patients. In the urokinase pulmonary embolism trial (UPET) (19),
94% of patients with documented emboli had one or more recognized predisposing conditions. Only 5% of the patients in our
study had no identifiable risk factors.
Syndromes
Categorizing pulmonary embolism in terms of syndromes
helps to clarify the presenting clinical diagnostic pattems. The
syndromes of pulmonary embolism include the circulatory collapse syndrome, pulmonary infarction syndrome, and uncomplicated pulmonary embolism syndrome (12).
By recognizing the various presenting syndromes of acute
pulmonary embolism, the clinician can estimate the hemodynamic impact of the embolic event. In the study by Stein et al
(11), the pulmonary angiographic severity scores were higher in
syndromes characterized by circulatory collapse and the uncomplicated embolism syndrome. In contrast, the angiographic
index of severity was lower in patients with the pulmonary
infarction syndrome. Thames et al (20) found that most of the
patients with syncope demonstrated 50% or greater obstmction
of pulmonary blood flow.
Symptoms and physical findings
Several clinical studies have demonstrated the difficulty of
diagnosing pulmonary embolism based on the history and physical examination (2,3). Nevertheless, some clues have been
found based upon common but nonspecific signs and symptoms. Among patients with pulmonary embolism without preexisting cardiac or pulmonary disease. Stein et al (11) found that
96% had either dyspnea, tachypnea, or clinical signs of deep
venous thrombosis. Our experience paralleled these observations, with either dyspnea or tachypnea occurring in 96% of our
patients. The absence of dyspnea and/or tachypnea would be
strong evidence for exclusion of the diagnosis.
Data collected from the UPET (19) revealed that the triad of
pleuritic chest pain, hemoptysis, and thrombophlebitis was
present in only 4% of patients with acute pulmonary embolus.
The same study also showed that the triad of dyspnea, pleuritic
chest pain, and hemoptysis was observed in only 28% of patients
with pulmonary embolism. From our review, the combination
of dyspnea, pleuritic chest pain, and hemoptysis was seen in
23% of patients. Stein et al (11) analyzed a subset of patients
from the UPET study who had no history of previous cardiopulmonary disease. They found, even among patients with
no cardiac or pulmonary disease, that the combination of dyspnea, pleuritic chest pain, and hemoptysis occurred in only 22%
of patients with acute pulmonary embolism.
Arterial blood gases
Hypoxemia is a consistent and important clinical feature of
acute pulmonary embolism and is present in most patients with
pulmonary embolism (21). Bell etal (3) reported that the average
PaO, was 60 mm Hg and that 10%> of the patients had a PaO,
greaterthan 80 mm Hg. McNeil et al (21) showed that no significant difference occurred in the PaO, of young patients with
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pleuritic chest pain who did or did not have pulmonary emboli.
In an editorial by Martin (22) conceming PaO, data from phase 2
ofthe UPET study, he contended that a PaO, above 80 mm Hg as
being "nonnal" may be misleading without knowledge of the
PaCO, and the alveolar-arterial gradient to allow for estimation
ofthe contribution of hyperventilation to normoxemia. The Figure illustrates the varied ranges of partial pressure of oxygen in
our patients with acute pulmonary embolism. As noted, most
patients demonstrated moderate hypoxemia; however, 9% had a
PaOj greater than 80 mm Hg, which is in accordance with Bell et
al's study (3). However, the alveolar-arterial gradients were not
evaluated.
Using their inert gas technique, Wagner et al (23) studied the
causes of hypoxemia. Recent investigators, using this method,
demonstrated that during the initial phase of the pulmonary embolic event hypoxemia was the result of perfusion of lung units
with a low ventilation/perfusion ratio. Shunt as a major factor of
hypoxemia was noted to occur later in the course of the embolic
event (48 hours or more) and only if atelectasis or other factors
leading to loss in lung volume were present (24).
Chest radiographic findings
A normal chest radiograph was found in 18% of the patients
in our series. The presence of a normal chest radiograph was
seen in 24% of 169 patients with angiographically proven
pulmonary embolism in the National Heart, Lung and Blood
Institute (NHLBI) urokinase-streptokinase pulmonary embolism trials (25).
In our review, the most frequent radiographic findings
were infiltration, pleural effusion, and atelectasis. These
parenchymal signs were more common in patients with the pulmonary infarction syndrome. Other chest radiographic abnormalities may include elevation of the hemidiaphragm on the side
ofthe embolus, enlarged pulmonary arteries, a difference in
vascularity of the two sides (Westermark's sign), and cardiomegaly secondary to right ventricular enlargement (25).
Greenspan et al (26) evaluated whether the chest radiograph
alone could be used to diagnose or exclude pulmonary embolism. These investigators found that the chest x-ray can provide
additional information, especially to exclude other disease processes (rib fracture or pneumothorax). On the other hand. Stein
et al (25) found frequent radiographic signs that may give clues
to the diagnosis. In particular, an elevated hemidiaphragm was
found in 26% of patients with pulmonary embolism. In our
study, the chest x-ray report of an elevated hemidiaphragm
was rare (only 5%), but this may have represented a lack of description of this finding. It would be important to consider a
normal chest x-ray, in the clinical sening of acute dyspnea with
hypoxemia and no evidence of bronchospasm, to be strongly
suggestive of acute pulmonary embolism.
Electrocardiogram
In patients without prior cardiopulmonary disease, electrocardiographic abnormalities were present in 87% of 90 patients with angiographically documented emboli (27). The most
common abnormalities were nonspecific T-wave changes in
42% of patients, with RST-segment abnormalities present in
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41%. We also found nonspecific ST segment and T-wave
changes to be the most common abnormality. Left axis deviation
and right axis deviation occurred at equal frequency (7%) (27).
Signs of cor pulmonale (S.QjT,, right bundle branch block, Ppulmonale, or right axis deviation) were noted in 26% of patients with submassive pulmonary embolism and in 32% with
massive pulmonary embolism (27). Although we did not separate our patient group into massive or submassive categories,
we noted that in six of 14 with syncope or shock a new right bundle branch block was present. In the UPET study (19), 23% of
patients with submassive pulmonary embolism had normal
electrocardiograms, whereas in our study 10% of patients had
normal electrocardiograms. Although no specific electrocardiographic features are diagnosric of pulmonary embolism,
these nonspecific ECG abnormalities in the proper clinical setting support the diagnosis.
Arrhythmias occurred in 12% of our patients, most of which
were atrial fibrillation or atrial flutter. This finding occurred
more frequently in our study than in others, which we cannot
explain. In 90 patients with pulmonary emboli without previous
cardiopulmonary disease, no arrhythmia occurred (27). Of the
23 patients with acute pulmonary embolism and no heart disease
in Szucs et al's study (28), only 4% had atrial flutter or atrial fibrillation. Even in patients who had previous cardiac or
pulmon.i.ry disease, only 3% had premature atrial contractions,
5% had atrial fibrillation, and 9% had premature ventricular
contractions (19).
Lung scans
The clinical utility of ventilation perfusion imaging has come
under considerable controversy recently, especially in regard
to focusing on the sensitivity and specificity of this noninvasive test (29). Several retrospective studies have compared
scintigraphic findings with pulmonary angiographic findings,
resulting in different criteria for the interpretation of ventilation
perfusion scans in patients with pulmonary embolism (30,31).
These studies showed that a scan pattem characterized as multiple mismatched perfusion defects, involving greater than 75%
of the bronchopulmonary segment, is associated with a high
probability of pulmonary embolism (90%). In a lung scan that
demonstrates perfusion defects, matching with radiographic and
ventilation abnormalities, the likelihood of pulmonary embolism is indeterminate (25% to 35%). A scan pattem which shows
that all perfusion defects are less than 25% of the segment and
are matched with ventilation abnormalities but not to chest
radiographic abnormalities has a low likelihood of pulmonary
embolism (less than 10%).
This scheme has been challenged by a prospective Canadian
study (29), which suggests that low probability scan patterns
may be associated with a higher incidence of venous thromboemboli than previously reported. Nevertheless, a completely
normal ventilation perfusion scan virtually eliminates the diagnosis of pulmonary embolism (32,33).
Our institution is currently involved with a multicentered
NHLBI study of the prospective investigation of pulmonary
embolism diagnosis (PIOPED), which assesses the efficacy of
ventilation perfusion scanning.
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Pulmonary angiography
Pulmonary angiography continues to be the "gold standard" test
for the diagnosis of pulmonary embolism (7,8). In the UPET study
(19), in which over 800 pulmonary angiograms were pjerformed,
the morbidity was less than 1% and the mortality was less than
0.01%. A review of 1,350 angiograms performed at Duke Medical
Center over an 11 -year period revealed only three deaths (34). There
were no angiographically related deaths in our series.
A negative pulmonary angiogram, despite even a strong clinical
suspicion, excludes the diagnosis of pulmonary embolism. Among
167 patients with clinically suspected pulmonary embolism who
had negative pulmonary angiograms and who were followed for six
months, none had a clinical event suggestive of pulmonary embolism (35). Those who died and had postmortem examinations did
not demonstrate pulmonary emboli.

Summary
We retrospectively reviewed the clinical features, laboratory
data, chest radiographic reports, and lung scans of patients with
angiographically proven pulmonary embolism to reassess the
features of pulmonary embolism which may assist the clinician
in selecting patients for confirmatory diagnostic studies. We realize evaluation of the clinical features of pulmonary embolism
only in those patients with angiographic documentation creates
a degree of bias when determining these clinical characteristics.
The clinical features of pulmonary embolism have been demonstrated in the literature as being nonspecific. However, the
following clinical parameters should be sought in selecting
patients with suspected pulmonary embolism for pulmonary
angiography: 1) appropriate predisposing factors; 2) an acute,
unexplained onset of dyspnea, tachypnea, or tachycardia; 3) arterial blood gases demonstrating hypoxemia or a widening of
the alveolar-arterial oxygen gradient; 4) an electrocardiogram
showing nonspecific ST segment and T-wave changes; 5) a normal chest radiograph in the presence of unexplained dyspnea or
showing an elevated hemidiaphragm or parenchymal abnormalities; and 6) abnormal ventilation perfusion scans, which,
whether of low or indeterminate probability, in the presence of
the abovefindingswarrant angiographic pursuit.
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